COMMUNIQUÉS West-GlobeNewswire

MDxHealth Shareholder Transparency Declaration MDxHealth (R):
17/10/2018
Press release Regulated information 16 October 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - October 16, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
17/10/2018
C ommuniqué de presse Information réglementée 17 octobre 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 17 octobre 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir [...]
Nicox : Point d'activité et résumé financier du troisième trimestre 2018
17/10/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du troisième trimestre 2018 Initiation d'une étude clinique de phase 2 pour NCX 470 au troisième trimestre 2018 pour la réduction de la pression [...]
Nicox Third Quarter 2018 Business Update and Financial Highlights
17/10/2018
Press Release Nicox Third Quarter 2018 Business Update and Financial Highlights NCX 470 Phase 2 clinical study initiated in Q3 2018 for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or [...]
Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver
17/10/2018
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the Outsourcing in Clinical Trials event in Vancouver, Canada October 16 [...]
Eloxx Pharmaceuticals To Report Third Quarter 2018 Financial Results and Provide Business Update On November 8, 2018
17/10/2018
Company management to host a webcast and conference call to provide a business update and review the financial results at 8:30 a.m. ET WALTHAM, Mass., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. ( [...]
Helix BioPharma Corp. Extends Period to Exercise Warrants
17/10/2018
RICHMOND HILL, Ontario, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Sirona Biochem Announces Close of Financing and Extension of Convertible Notes
17/10/2018
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (the “ Company ”) announced that it has closed a private placement (subject to TSX.V approval) in the [...]
AIT Therapeutics to Present High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference
16/10/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth
16/10/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 16, [...]
FibroGen Announces Four Clinical Presentations on Roxadustat at Upcoming American Society of Nephrology Kidney Week 2018 Annual Meeting
16/10/2018
Roxadustat Phase 3 Clinical Results in Late-Breaking Clinical Trial Posters and Oral Presentation SAN FRANCISCO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company [...]
Ziopharm Oncology Announces Changes to Board of Directors and Management Team
16/10/2018
-- CEO Laurence Cooper Appointed to Board of Directors -- Francois Lebel to Depart Company BOSTON, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a biotechnology company focused on development [...]
Stratice Healthcare announces eOrdersPlus Integration with Brightree
16/10/2018
eOrdersPlus™ solution enabling direct eOrdering connectivity between healthcare professionals & providers of patients’ medical equipment, supplies and service needs now bridges last mile of electronic connectivity [...]
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease
16/10/2018
SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural [...]
Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call
16/10/2018
MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, [...]
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Late Stage Prostate Cancer
16/10/2018
BATON ROUGE, La., Oct. 16, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Pfizer’s TALZENNA® (talazoparib)
16/10/2018
SALT LAKE CITY, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has [...]
Information concerning the total number of voting rights and shares
16/10/2018
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]
Informations relatives au nombre total de droits de vote et d'actions
16/10/2018
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Pages